New USF study tests whether AI can reliably predict immune responses
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 13-Jun-2026 21:15 ET (14-Jun-2026 01:15 GMT/UTC)
Artificial intelligence is increasingly being used to help scientists accelerate drug discovery and search for new treatments. But for AI tools to work effectively, researchers need to know whether they can be validated and applied in real-world situations. A team at the University of South Florida is taking a step in that direction by merging AI and immunology in ways that could enhance oncology treatment and the development of new drugs and vaccines.
Congratulations to Prof. Dafna Kariv, Head of the Entrepreneurship–Business Administration track at the Adelson School of Entrepreneurship at Reichman University, on being awarded the Inspiration Award in the ETF New Learning Award 2026 competition, presented by the European Training Foundation (ETF), an agency of the European Commission, to groundbreaking initiatives in teaching and learning.
The UK‑led OpenBind initiative has reached a major milestone with the release of its first publicly available dataset , a groundbreaking step toward accelerating the discovery of new medicines using artificial intelligence. The release makes high‑quality, standardised experimental data freely accessible to researchers worldwide, providing AI-ready data to address the most persistent barriers in AI‑driven therapeutic development.